Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent

Pathophysiology of Haemostasis and Thrombosis

Volumn 34, Issue 4-5, 2006, Pages 177-183

  Minea, Radu ^a   Swenson, Stephen ^a   Costa, Fritz ^a   Chen, Thomas C ^a   Markland, Francis S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anti angiogenesis; Breast cancer; Contortrostatin; Recombinant disintegrin; Snake venom

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CONTORTROSTATIN; DISINTEGRIN; INTEGRIN; LIPOSOME; SNAKE VENOM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FORMULATION; ENCAPSULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SNAKE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CLONING, MOLECULAR; DISINTEGRINS; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; HUMANS; LIPOSOMES; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 33646794420     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092419     Document Type: Conference Paper

References (13)

1. Zhou Q, Hu P, Ritter MR, Swenson SD, Argounova S, Epstein AL, Markland FS: Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom. Arch Biochem Biophys 2000;375:278-288.
2. Bardwell JC, McGovern K, Beckwith J: Identification of a protein required for disulfide bond formation in vivo. Cell 1991;67:581-589.
3. Prinz WA, Aslund F, Holmgren A, Beckwith J: The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J Biol Chem 1997;272:15661-15667.
4. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW: Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990;185:60-89.
5. Dubendorff JW, Studier FW: Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor. J Mol Biol 1991;219:45-59.
6. Studier FW: Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J Mol Biol 1991;219:37-44.
7. LaVallie ER, DiBlasio EA, Kovacic S, Grant KL, Schendel PF, McCoy JM: A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 1993;11:187-193.
8. Wierzbicka-Patynowski I, Niewiarowski S, Marcinkiewicz C, Calvete JJ, Marcinkiewicz MM, McLane MA: Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins. J Biol Chem 1999;274:37809-37814.
9. Zhou Q, Nakada MT, Arnold C, Markland FS: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis. Angiogenesis 1999;3:259-269.
10. Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei D, Markland FS: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res Treat 2000;61:249-260.
11. Markland FS, Shieh K, Zhou Q, Golubkov V, Sherwin RP, Richters V, Sposto R: A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 2001;31:183-191.
12. Newman PJ: The role of PECAM-1 in vascular cell biology. Ann NY Acad Sci 1994;714:165-174.
13. Fujii Y, Okuda D, Fujimoto Z, Horii K, Morita T, Mizuno H: Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol 2003;332: 1115-1122.